BG60444B2 - Метод за получаване на избран протеин - Google Patents
Метод за получаване на избран протеин Download PDFInfo
- Publication number
- BG60444B2 BG60444B2 BG098458A BG9845894A BG60444B2 BG 60444 B2 BG60444 B2 BG 60444B2 BG 098458 A BG098458 A BG 098458A BG 9845894 A BG9845894 A BG 9845894A BG 60444 B2 BG60444 B2 BG 60444B2
- Authority
- BG
- Bulgaria
- Prior art keywords
- protein
- bacterial
- polypeptide
- gene
- periplasmic
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 78
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 34
- 230000001580 bacterial effect Effects 0.000 claims abstract description 29
- 241000894006 Bacteria Species 0.000 claims abstract description 9
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 23
- 108010087702 Penicillinase Proteins 0.000 claims description 19
- 108010078791 Carrier Proteins Proteins 0.000 claims description 18
- 229920001184 polypeptide Polymers 0.000 claims description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 18
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 18
- 108010077805 Bacterial Proteins Proteins 0.000 claims description 17
- 102000014914 Carrier Proteins Human genes 0.000 claims description 17
- 239000012634 fragment Substances 0.000 claims description 15
- 241000588724 Escherichia coli Species 0.000 claims description 14
- 229940125396 insulin Drugs 0.000 claims description 13
- 239000013612 plasmid Substances 0.000 claims description 13
- 108090001061 Insulin Proteins 0.000 claims description 11
- 229950009506 penicillinase Drugs 0.000 claims description 11
- 102000004877 Insulin Human genes 0.000 claims description 10
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 102000053602 DNA Human genes 0.000 claims description 7
- 108010090127 Periplasmic Proteins Proteins 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 3
- 230000029142 excretion Effects 0.000 claims description 3
- 108020000946 Bacterial DNA Proteins 0.000 claims description 2
- 108091008146 restriction endonucleases Proteins 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000010367 cloning Methods 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 37
- 108020004414 DNA Proteins 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 102000037865 fusion proteins Human genes 0.000 description 10
- 108020001507 fusion proteins Proteins 0.000 description 10
- 239000000427 antigen Substances 0.000 description 9
- 230000000890 antigenic effect Effects 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 108091007433 antigens Proteins 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000011534 wash buffer Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000002285 radioactive effect Effects 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 210000001322 periplasm Anatomy 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 108010066381 preproinsulin Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102100031780 Endonuclease Human genes 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010076181 Proinsulin Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 108010067390 Viral Proteins Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100028672 C-type lectin domain family 4 member D Human genes 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 101000766905 Homo sapiens C-type lectin domain family 4 member D Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000588778 Providencia stuartii Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000002342 anti-penicillin Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 108091092330 cytoplasmic RNA Proteins 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/30—Signal or leader sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/913,533 US4411994A (en) | 1978-06-08 | 1978-06-08 | Protein synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
BG60444B2 true BG60444B2 (bg) | 1995-03-31 |
Family
ID=25433372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG098458A BG60444B2 (bg) | 1978-06-08 | 1994-02-11 | Метод за получаване на избран протеин |
Country Status (20)
Country | Link |
---|---|
US (1) | US4411994A (ja) |
EP (1) | EP0006694B2 (ja) |
JP (2) | JPS5519092A (ja) |
AT (1) | ATE5001T1 (ja) |
AU (1) | AU524856B2 (ja) |
BG (1) | BG60444B2 (ja) |
CA (1) | CA1215920A (ja) |
DD (1) | DD148235A5 (ja) |
DE (1) | DE2966291D1 (ja) |
DK (1) | DK237979A (ja) |
ES (1) | ES481362A1 (ja) |
FI (1) | FI791841A (ja) |
GR (1) | GR72953B (ja) |
IE (1) | IE48156B1 (ja) |
IL (1) | IL57491A (ja) |
MX (1) | MX6339E (ja) |
NZ (1) | NZ190524A (ja) |
PT (1) | PT69737A (ja) |
WO (1) | WO1980000030A1 (ja) |
ZA (1) | ZA792486B (ja) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR7807290A (pt) * | 1977-11-08 | 1979-06-12 | Genentech Inc | Plasmideo,processo para producao de um polipeptido especifico veiculo clonal,cultura bacteriana transformante,processo para produzir uma substancia imunogenica processo para preparar um gene estrutural,e polidesoxirribonucleotido de faixa dupla |
US6297355B1 (en) | 1978-12-22 | 2001-10-02 | Biogen, Inc. | Polypeptides displaying HBV antigenicity or hbv antigen specificity |
US4342832A (en) * | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
GR70279B (ja) * | 1979-09-12 | 1982-09-03 | Univ California | |
DE3001928A1 (de) * | 1980-01-19 | 1981-08-06 | Hoechst Ag, 6000 Frankfurt | Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus |
US6455275B1 (en) | 1980-02-25 | 2002-09-24 | The Trustees Of Columbia University In The City Of New York | DNA construct for producing proteinaceous materials in eucaryotic cells |
CA1200773A (en) * | 1980-02-29 | 1986-02-18 | William J. Rutter | Expression linkers |
US4711843A (en) * | 1980-12-31 | 1987-12-08 | Cetus Corporation | Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis |
AU545912B2 (en) * | 1980-03-10 | 1985-08-08 | Cetus Corporation | Cloned heterologous jive products in bacillies |
DE3177213D1 (de) | 1980-04-03 | 1990-10-18 | Biogen Inc | Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon. |
US4338397A (en) * | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
US6610830B1 (en) | 1980-07-01 | 2003-08-26 | Hoffman-La Roche Inc. | Microbial production of mature human leukocyte interferons |
IT1139487B (it) * | 1980-09-25 | 1986-09-24 | Genentech Inc | Produzione microbica di interferone di fibroblasti umani |
US4394443A (en) * | 1980-12-18 | 1983-07-19 | Yale University | Method for cloning genes |
FI64813C (fi) * | 1980-12-31 | 1984-01-10 | Ilkka Antero Palva | Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer |
DK582381A (da) * | 1981-01-02 | 1982-07-03 | Univ New York | Remkombinat plasmid til anvendelse ved bakteriel kloning |
NZ199391A (en) * | 1981-01-02 | 1985-12-13 | Genentech Inc | Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin |
US4663285A (en) * | 1981-01-06 | 1987-05-05 | The Public Health Laboratory Service Board | Chimeric plasmids |
ZA824218B (en) * | 1981-06-29 | 1983-04-27 | Cetus Corp | Plasmid for producing human insulin |
JPS5869897A (ja) * | 1981-10-20 | 1983-04-26 | Gakuzo Tamura | Dna遺伝子 |
EP0078154A3 (en) * | 1981-10-28 | 1985-01-09 | The Regents Of The University Of California | Plasmids and cells for heterologous expression of metallothioneins and processes for producing and using the metallothionein |
US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
US4863855A (en) * | 1982-05-14 | 1989-09-05 | The Research Foundation Of State University Of New York | Novel cloning vehicles for polypeptide expression in microbial hosts |
JPS592689A (ja) * | 1982-06-04 | 1984-01-09 | Handai Biseibutsubiyou Kenkyukai | 強力な遺伝子発現能を有する新規レプリコンの作成法 |
US4595658A (en) * | 1982-09-13 | 1986-06-17 | The Rockefeller University | Method for facilitating externalization of proteins synthesized in bacteria |
DE3382547D1 (de) * | 1983-01-12 | 1992-05-27 | Chiron Corp | Sekretorische expression in eukaryoten. |
SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
DK138984A (da) * | 1983-03-08 | 1984-09-09 | Rikagaku Kenkyusho | Plasmid, fremgangsmaade til fremstilling heraf, mikroorganismer indeholdende samme samt fremgangsmaade til dyrkning af mikroorganismen |
JPS59162874A (ja) * | 1983-03-08 | 1984-09-13 | Rikagaku Kenkyusho | 微生物の培養方法 |
US4962055A (en) * | 1983-03-08 | 1990-10-09 | Rikagaku Kenkyusho | Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism |
US4711844A (en) * | 1983-03-09 | 1987-12-08 | Cetus Corporation | Modified signal peptides |
US4820642A (en) * | 1983-04-04 | 1989-04-11 | The Regents Of The University Of California | Amplified expression vector |
JPS60501140A (ja) * | 1983-04-22 | 1985-07-25 | アムジエン | 酵母による外因性ポリペプチドの分泌 |
US7198919B1 (en) | 1983-04-25 | 2007-04-03 | Genentech, Inc. | Use of alpha factor sequences in yeast expression systems |
EP0123228B1 (en) * | 1983-04-25 | 1993-09-29 | Chiron Corporation | Hybrid dna synthesis of mature insulin-like growth factors |
US4663280A (en) * | 1983-05-19 | 1987-05-05 | Public Health Research Institute Of The City Of New York | Expression and secretion vectors and method of constructing vectors |
GB8314362D0 (en) * | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
FR2549855B1 (fr) * | 1983-07-29 | 1987-03-27 | Grp Genie Genetique | Sequence nucleotidique codant pour le peptide signal de la toxine diphterique, vecteur contenant cette sequence nucleotidique, leur application a la transformation de micro-organismes et compositions peptidiques obtenues |
JPH0646946B2 (ja) * | 1984-03-30 | 1994-06-22 | 三菱化成株式会社 | 蛋白の産生方法 |
US4695542A (en) | 1983-10-04 | 1987-09-22 | Dnax Research Institute Of Molecular And Cellular Biology, Inc. | cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity |
NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
KR850004274A (ko) * | 1983-12-13 | 1985-07-11 | 원본미기재 | 에리트로포이에틴의 제조방법 |
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
PH23920A (en) * | 1983-12-20 | 1990-01-23 | Cetus Corp | Glucoamylase cdna |
IT1185503B (it) * | 1984-01-11 | 1987-11-12 | Univ New York | Cloni di odna di eritropietina umana |
US4859465A (en) * | 1984-04-20 | 1989-08-22 | The Regents Of The University Of California | Vaccine capable of eliciting multivalent antibodies |
DK58285D0 (da) * | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
US5668255A (en) * | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
US6022950A (en) * | 1984-06-07 | 2000-02-08 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
US4801537A (en) * | 1984-06-08 | 1989-01-31 | Genex Corporation | Vector for expression of polypeptides in bacilli |
US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
JPH062074B2 (ja) * | 1984-07-27 | 1994-01-12 | 國男 山根 | オリゴペプチドの製法 |
JP2524695B2 (ja) * | 1984-12-26 | 1996-08-14 | 湧永製薬株式会社 | 蛋白質の製造法 |
JP2524693B2 (ja) * | 1984-07-30 | 1996-08-14 | 湧永製薬株式会社 | 蛋白質の製造法 |
DE3587205T2 (de) * | 1984-07-30 | 1993-08-26 | Wakunaga Seiyaku Kk | Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle. |
US5691181A (en) * | 1984-08-21 | 1997-11-25 | Celltech Limited | DNA encoding lipase from human gastric mucosal tissue |
JPS61268183A (ja) * | 1985-05-24 | 1986-11-27 | Wakamoto Pharmaceut Co Ltd | Dna,組換体dnaおよびそれらを含む微生物 |
US5272254A (en) * | 1984-10-02 | 1993-12-21 | Biogen Inc. | Production of streptavidin-like polypeptides |
DE3583940D1 (de) * | 1984-10-02 | 1991-10-02 | Harry M Meade | Herstellung von streptavidinaehnlichen polypeptiden. |
US4963495A (en) * | 1984-10-05 | 1990-10-16 | Genentech, Inc. | Secretion of heterologous proteins |
JPH0817702B2 (ja) * | 1984-12-28 | 1996-02-28 | 理化学研究所 | 新規プラスミド及びその調製方法並びにそのプラスミドを含有する新規微生物 |
US5190874A (en) * | 1984-12-28 | 1993-03-02 | Rikagaku Kenkyusho | Method for producing penicillinase and xylanase |
US4774180A (en) * | 1986-02-26 | 1988-09-27 | Massachusetts Institute Of Technology | Construction and application of polyproteins |
JP2500311B2 (ja) * | 1985-03-19 | 1996-05-29 | 工業技術院長 | 蛋白製造法 |
JP2620852B2 (ja) * | 1985-07-30 | 1997-06-18 | 理化学研究所 | 新規プラスミド及びそれにより形質転換された新規微生物 |
PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
USH2055H1 (en) | 1985-09-20 | 2002-12-03 | Zymogenetics, Inc. | Expression of tissue-type plasminogen activator in bacteria |
WO1987002037A1 (en) * | 1985-09-26 | 1987-04-09 | Genetics Institute, Inc. | Pulmonary surfactant proteins |
AU6408586A (en) * | 1985-10-03 | 1987-04-24 | Biotechnology Research Partners Limited | Novel lipoprotein-based drug-delivery systems |
GB8529014D0 (en) * | 1985-11-25 | 1986-01-02 | Biogen Nv | Enhanced secretion of heterologous proteins |
JPH0669377B2 (ja) * | 1985-11-25 | 1994-09-07 | 工業技術院長 | Dna塩基配列およびベクタ− |
US4929700A (en) * | 1987-04-16 | 1990-05-29 | Cetus Corporation | Production of purified, biologically active, bacterially produced recombinant human CSF-1 |
CA1339757C (en) * | 1987-04-16 | 1998-03-17 | Robert F. Halenbeck | Production of purified biologically active, bacterially produced recombinant human csf-1 |
US5084384A (en) * | 1987-04-23 | 1992-01-28 | Monsanto Company | Secretion of insulin-like growth factor-I |
US5426036A (en) * | 1987-05-05 | 1995-06-20 | Hoechst Aktiengesellschaft | Processes for the preparation of foreign proteins in streptomycetes |
US5066792A (en) * | 1987-09-04 | 1991-11-19 | Board Of Regents University Of Texas | Gene probe for detection of specific human leukemias |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
JPH04500970A (ja) | 1988-09-02 | 1992-02-20 | ザ ロックフェラー ユニヴァーシティ | マクロファージ由来炎症メディエーター (mip―2) |
FR2648713B1 (fr) * | 1989-06-26 | 1994-06-10 | Commissariat Energie Atomique | Proteines hybrides entre une enzyme extracytoplasmique et une autre proteine, leur procede de preparation, ainsi que leur application comme agent de diagnostic |
US7413537B2 (en) * | 1989-09-01 | 2008-08-19 | Dyax Corp. | Directed evolution of disulfide-bonded micro-proteins |
US5578464A (en) * | 1989-10-31 | 1996-11-26 | Schering Corporation | E. coli secretory strains |
US5595900A (en) * | 1990-02-14 | 1997-01-21 | The Regents Of The University Of Michigan | Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
WO1992006191A1 (en) * | 1990-09-28 | 1992-04-16 | Protein Engineering Corporation | Proteinaceous anti-dental plaque agents |
DK1279731T3 (da) * | 1991-03-01 | 2007-09-24 | Dyax Corp | Fremgangsmåde til udvikling af bindende miniproteiner |
WO1994020079A1 (en) | 1993-03-10 | 1994-09-15 | Smithkline Beecham Corporation | Human brain phosphodiesterase |
US5691180A (en) * | 1994-06-09 | 1997-11-25 | The Regents Of The University Of Michigan | DNA sequence encoding N-acetyl-galactosamine-transferase |
US5807732A (en) * | 1995-02-28 | 1998-09-15 | Lowe; John B. | GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferases, DNA sequences encoding the same, method for producing the same and a method of genotyping a person |
US5770420A (en) * | 1995-09-08 | 1998-06-23 | The Regents Of The University Of Michigan | Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures |
US6087128A (en) * | 1998-02-12 | 2000-07-11 | Ndsu Research Foundation | DNA encoding an avian E. coli iss |
US7858339B1 (en) | 1998-10-28 | 2010-12-28 | Genentech, Inc. | Process for bacterial production of polypeptides |
CN101410520B (zh) * | 2003-04-29 | 2012-05-30 | 金克克国际有限公司 | 新颖的杆菌029cel纤维素酶 |
US7449318B2 (en) * | 2003-04-30 | 2008-11-11 | Danisco A/S, Genencor Division | Bacillus mHKcel cellulase |
US7892807B2 (en) * | 2003-04-30 | 2011-02-22 | Danisco Us Inc. | Bacillus BagCel cellulase |
WO2004101760A2 (en) * | 2003-05-12 | 2004-11-25 | Genencor International, Inc. | Novel lipolytic enzyme elip |
US20070213518A1 (en) * | 2003-05-12 | 2007-09-13 | Jones Brian E | Novel Lipolytic Enzyme Lip2 |
WO2004101763A2 (en) | 2003-05-12 | 2004-11-25 | Genencor International, Inc. | Novel lipolytic enzyme lip1 |
CA3180326A1 (en) | 2020-04-20 | 2021-10-28 | Vestaron Corporation | Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control |
CN116096236A (zh) | 2020-05-01 | 2023-05-09 | 韦斯塔隆公司 | 杀昆虫组合 |
KR20230078719A (ko) | 2020-09-28 | 2023-06-02 | 베스타론 코포레이션 | 해충 방제용 뮤-디구에톡신-Dc1a 변이형 폴리펩타이드 |
IL307293A (en) | 2021-04-01 | 2023-11-01 | Vestaron Corp | AV3 mutant polypeptides for pest control |
EP4312536A1 (en) | 2021-04-01 | 2024-02-07 | Vestaron Corporation | Liposome formulations for pesticide delivery and methods for producing and using the same |
IL313184A (en) | 2021-11-29 | 2024-07-01 | Ironwood Pharmaceuticals Inc | Medicinal preparations for the treatment of visceral pain |
WO2023192924A1 (en) | 2022-03-30 | 2023-10-05 | Vestaron Corporation | Combinations of av3 mutant polypeptides and bt toxins for pest control |
WO2023225555A1 (en) | 2022-05-18 | 2023-11-23 | Vestaron Corporation | Pesticidal actx peptide variants |
WO2023245128A1 (en) | 2022-06-17 | 2023-12-21 | Vestaron Corporation | Antimicrobial peptide |
WO2023245169A1 (en) | 2022-06-17 | 2023-12-21 | Vestaron Corporation | Antimicrobial peptide combinations |
WO2023245100A1 (en) | 2022-06-17 | 2023-12-21 | Vestaron Corporation | Antimicrobial ncr13 variant peptides |
WO2024026406A2 (en) | 2022-07-29 | 2024-02-01 | Vestaron Corporation | Next Generation ACTX Peptides |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4082613A (en) * | 1976-04-23 | 1978-04-04 | The Regents Of The University Of Minnesota | Process for the production of insulin by genetically transformed fungal cells |
JPS53137215A (en) * | 1977-05-06 | 1978-11-30 | Harima Refractories Co Ltd | Reparing material of blast oven gate by spray method |
NO158880C (no) * | 1977-11-08 | 1988-11-09 | Genentech Inc | Fremgangsmaate for fremstilling av et spesifikt pattedyrhormon. |
GB2007676B (en) * | 1977-11-08 | 1982-09-08 | Genentech Inc | Method and means for microbial polypeptide expression |
-
1978
- 1978-06-08 US US05/913,533 patent/US4411994A/en not_active Expired - Lifetime
-
1979
- 1979-05-02 ZA ZA792486A patent/ZA792486B/xx unknown
- 1979-05-22 NZ NZ190524A patent/NZ190524A/xx unknown
- 1979-05-24 GR GR59168A patent/GR72953B/el unknown
- 1979-06-04 EP EP79301054A patent/EP0006694B2/en not_active Expired - Lifetime
- 1979-06-04 JP JP6901879A patent/JPS5519092A/ja active Granted
- 1979-06-04 AT AT79301054T patent/ATE5001T1/de active
- 1979-06-04 DE DE7979301054T patent/DE2966291D1/de not_active Expired
- 1979-06-05 AU AU47752/79A patent/AU524856B2/en not_active Ceased
- 1979-06-06 DD DD79213428A patent/DD148235A5/de unknown
- 1979-06-06 PT PT69737A patent/PT69737A/pt unknown
- 1979-06-06 IL IL57491A patent/IL57491A/xx unknown
- 1979-06-07 WO PCT/US1979/000399 patent/WO1980000030A1/en unknown
- 1979-06-07 ES ES481362A patent/ES481362A1/es not_active Expired
- 1979-06-07 DK DK237979A patent/DK237979A/da not_active Application Discontinuation
- 1979-06-07 MX MX798053U patent/MX6339E/es unknown
- 1979-06-08 CA CA000329373A patent/CA1215920A/en not_active Expired
- 1979-06-08 FI FI791841A patent/FI791841A/fi not_active Application Discontinuation
- 1979-08-08 IE IE1115/79A patent/IE48156B1/en unknown
-
1986
- 1986-03-26 JP JP61066115A patent/JPH0755151B2/ja not_active Expired - Lifetime
-
1994
- 1994-02-11 BG BG098458A patent/BG60444B2/bg unknown
Also Published As
Publication number | Publication date |
---|---|
EP0006694B1 (en) | 1983-10-12 |
CA1215920A (en) | 1986-12-30 |
JPS61227598A (ja) | 1986-10-09 |
PT69737A (en) | 1979-07-01 |
JPS5519092A (en) | 1980-02-09 |
GR72953B (ja) | 1984-01-18 |
WO1980000030A1 (en) | 1980-01-10 |
IL57491A0 (en) | 1979-10-31 |
AU524856B2 (en) | 1982-10-07 |
ZA792486B (en) | 1981-01-28 |
EP0006694A2 (en) | 1980-01-09 |
DD148235A5 (de) | 1981-05-13 |
NZ190524A (en) | 1982-09-14 |
ATE5001T1 (de) | 1983-10-15 |
EP0006694B2 (en) | 1992-01-22 |
IL57491A (en) | 1983-09-30 |
DE2966291D1 (en) | 1983-11-17 |
IE48156B1 (en) | 1984-10-17 |
IE791115L (en) | 1979-12-08 |
EP0006694A3 (en) | 1980-01-23 |
FI791841A (fi) | 1979-12-09 |
AU4775279A (en) | 1979-12-13 |
US4411994A (en) | 1983-10-25 |
JPS6246160B2 (ja) | 1987-09-30 |
JPH0755151B2 (ja) | 1995-06-14 |
DK237979A (da) | 1979-12-09 |
ES481362A1 (es) | 1980-03-01 |
MX6339E (es) | 1985-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG60444B2 (bg) | Метод за получаване на избран протеин | |
US4565785A (en) | Recombinant DNA molecule | |
US4782137A (en) | Synthesis of protein with an identification peptide, and hybrid polypeptide incorporating same | |
US4703004A (en) | Synthesis of protein with an identification peptide | |
JP2527438B2 (ja) | B型肝炎ウイルス抗原性を示すポリペプチドをコ−ドするdna配列 | |
EP0752886B1 (en) | Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes | |
JP2665359B2 (ja) | 免疫親和性による精製方法 | |
JP3126348B2 (ja) | 組換えにより生産されたヒトlh | |
IL86832A (en) | A recombinant DNA molecule containing a nucleotide sequence of part of the region encoding HBV pre-1s, an immunogenic particle containing multiple peptide monomers containing a pre-s1 epitope and pharmaceutical preparations containing it | |
WO1989006283A1 (en) | Novel plasmid vector with pectate lyase signal sequence | |
JPS61219395A (ja) | TGF‐βをコードしている核酸およびその用途 | |
PT99313B (pt) | Processo para a preparacao de proteinas, de viros recombinantes e de vectores de transferencia uteis para a expressao dessas proteinas | |
CN103224561A (zh) | 葡萄球菌肠毒素小分子抗体及制备方法及用途 | |
KR100257574B1 (ko) | 매독 트레포네마 융합 항원 및 그 융합 항원을 사용한 항매독 트레포네마 항체의 측정 방법 | |
US4820642A (en) | Amplified expression vector | |
ES2331573T3 (es) | Vector de expresion para la secrecion de un fragmento de anticuerpo usando una secuencia señal de e. coli y procedimiento para la produccion en serie del fragmento de anticuerpo. | |
JP2000503850A (ja) | S―層―タンパク質の組み換え発現 | |
KR840000949B1 (ko) | 유전자 재조합 단백질의 제조방법 | |
CN115010814B (zh) | 一种诺如病毒p颗粒嵌合棘球蚴eg95蛋白的重组蛋白及其应用 | |
CN111732667B (zh) | 小反刍兽疫病毒基因工程亚单位疫苗 | |
CN115947860A (zh) | 一种重组人促卵泡生成素Fc融合蛋白及制备方法 | |
CN116023448A (zh) | 牛源化鼠抗布鲁氏杆菌抗体及其制备方法与应用 | |
US20020182685A1 (en) | In vivo generation of antibodies against antigens secreted in a host by transfected MEL cells | |
JPS63245691A (ja) | ヒト免疫グロブリンGFc領域蛋白質およびその製造方法 | |
CN106916223A (zh) | 利用gst表达体系制备抗人pias3高效价抗体及应用 |